UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids

Proceedings of the National Academy of Sciences - PNAS, 2005-02, Vol.102 (8), p.3093-3098

2005

Volltextzugriff (PDF)

Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS

Proceedings of the National Academy of Sciences - PNAS, 2003-09, Vol.100 (18), p.10529-10533

2003

Volltextzugriff (PDF)

Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 Cannabinoid receptors

Anesthesiology (Philadelphia), 2003-10, Vol.99 (4), p.955-960

2003

Volltextzugriff (PDF)

Time-Dependent Descending Facilitation from the Rostral Ventromedial Medulla Maintains, But Does Not Initiate, Neuropathic Pain

The Journal of neuroscience, 2002-06, Vol.22 (12), p.5129-5136

2002

Volltextzugriff (PDF)

Sustained Morphine Exposure Induces a Spinal Dynorphin-Dependent Enhancement of Excitatory Transmitter Release from Primary Afferent Fibers

The Journal of neuroscience, 2002-08, Vol.22 (15), p.6747-6755

2002

Volltextzugriff (PDF)

Regular Exercise Reverses Sensory Hypersensitivity in a Rat Neuropathic Pain Model: Role of Endogenous Opioids

Anesthesiology (Philadelphia), 2011-04, Vol.114 (4), p.940-948

2011

Volltextzugriff (PDF)

NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study

Lancet neurology, 2008-12, Vol.7 (12), p.1106-1112

2008

Volltextzugriff (PDF)

CB2 cannabinoid receptor-mediated peripheral antinociception

Pain (Amsterdam), 2001-09, Vol.93 (3), p.239-245

2001

Volltextzugriff (PDF)

Role of NK-1 neurotransmission in opioid-induced hyperalgesia

Pain (Amsterdam), 2005-08, Vol.116 (3), p.276-288

2005

Volltextzugriff (PDF)

CB2 cannabinoid receptor mediation of antinociception

Pain (Amsterdam), 2006-05, Vol.122 (1-2), p.36-42

2006

Volltextzugriff (PDF)

Tonic Descending Facilitation from the Rostral Ventromedial Medulla Mediates Opioid-Induced Abnormal Pain and Antinociceptive Tolerance

The Journal of neuroscience, 2001-01, Vol.21 (1), p.279-286

2001

Volltextzugriff (PDF)

Parecoxib sodium, a parenteral cyclooxygenase 2 selective inhibitor, improves morphine analgesia and is opioid-sparing following total hip arthroplasty

Anesthesiology (Philadelphia), 2003-04, Vol.98 (4), p.950-956

2003

Volltextzugriff (PDF)

Dynorphin Promotes Abnormal Pain and Spinal Opioid Antinociceptive Tolerance

The Journal of neuroscience, 2000-09, Vol.20 (18), p.7074-7079

2000

Volltextzugriff (PDF)

The Cannabinoid agonist WIN55,212-2 suppresses opioid-induced emesis in ferrets

Anesthesiology (Philadelphia), 2001-05, Vol.94 (5), p.882-887

2001

Volltextzugriff (PDF)

CB2 cannabinoid receptor agonists: pain relief without psychoactive effects?

Current opinion in pharmacology, 2003-02, Vol.3 (1), p.62-67

2003

Volltextzugriff (PDF)

The cyclooxygenase-2-specific inhibitor parecoxib sodium is as effective as 12 mg of morphine administered intramuscularly for treating pain after gynecologic laparotomy surgery

Anesthesia and analgesia, 2005-02, Vol.100 (2), p.454-460

2005

Volltextzugriff (PDF)

Cardiovascular effects of sevoflurane compared with those of isoflurane in volunteers

Anesthesiology (Philadelphia), 1995-11, Vol.83 (5), p.918-928

1995

Volltextzugriff (PDF)

Spinal and Supraspinal Mechanisms of Neuropathic Pain

Annals of the New York Academy of Sciences, 2000-01, Vol.909 (1), p.12-24

2000

Volltextzugriff (PDF)

Production of paradoxical sensory hypersensitivity by alpha 2-adrenoreceptor agonists

Anesthesiology (Philadelphia), 2004-06, Vol.100 (6), p.1538-1544

2004

Volltextzugriff (PDF)

Lipid mediators regulating pain sensitivity

Prostaglandins & other lipid mediators, 2005-09, Vol.77 (1), p.123-130

2005

Volltextzugriff (PDF)

Differential blockade of nerve injury–induced thermal and tactile hypersensitivity by systemically administered brain-penetrating and peripherally restricted local anesthetics

The journal of pain, 2004-06, Vol.5 (5), p.281-289

2004

Volltextzugriff (PDF)

Neuropathic Pain: The Paradox of Dynorphin

Molecular interventions, 2001-08, Vol.1 (3), p.160

2001

Volltextzugriff (PDF)

Antinociceptive and nociceptive actions of opioids

Journal of neurobiology, 2004-10, Vol.61 (1), p.126-148

2004

Volltextzugriff (PDF)

Inhibition of pain responses by activation of CB(2) cannabinoid receptors

Chemistry and physics of lipids, 2002-12, Vol.121 (1-2), p.191-200

2002

Volltextzugriff (PDF)

PERIPHERAL NERVE INJURY CAUSES MULTISEGMENTAL ALLODYNIA AND A MULTISEGMENTAL INCREASE IN SPINAL DYNORPHIN CONTENT

Anesthesiology (Philadelphia), 1998-09, Vol.89 (Supplement), p.754

1998

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(50)

Sprache

Englisch
(50)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids

Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS

Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 Cannabinoid receptors

Time-Dependent Descending Facilitation from the Rostral Ventromedial Medulla Maintains, But Does Not Initiate, Neuropathic Pain

Sustained Morphine Exposure Induces a Spinal Dynorphin-Dependent Enhancement of Excitatory Transmitter Release from Primary Afferent Fibers

Regular Exercise Reverses Sensory Hypersensitivity in a Rat Neuropathic Pain Model: Role of Endogenous Opioids

NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study

CB2 cannabinoid receptor-mediated peripheral antinociception

Role of NK-1 neurotransmission in opioid-induced hyperalgesia

CB2 cannabinoid receptor mediation of antinociception

Tonic Descending Facilitation from the Rostral Ventromedial Medulla Mediates Opioid-Induced Abnormal Pain and Antinociceptive Tolerance

Parecoxib sodium, a parenteral cyclooxygenase 2 selective inhibitor, improves morphine analgesia and is opioid-sparing following total hip arthroplasty

Dynorphin Promotes Abnormal Pain and Spinal Opioid Antinociceptive Tolerance

The Cannabinoid agonist WIN55,212-2 suppresses opioid-induced emesis in ferrets

CB2 cannabinoid receptor agonists: pain relief without psychoactive effects?

The cyclooxygenase-2-specific inhibitor parecoxib sodium is as effective as 12 mg of morphine administered intramuscularly for treating pain after gynecologic laparotomy surgery

Cardiovascular effects of sevoflurane compared with those of isoflurane in volunteers

Spinal and Supraspinal Mechanisms of Neuropathic Pain

Production of paradoxical sensory hypersensitivity by alpha 2-adrenoreceptor agonists

Lipid mediators regulating pain sensitivity

Differential blockade of nerve injury–induced thermal and tactile hypersensitivity by systemically administered brain-penetrating and peripherally restricted local anesthetics

Neuropathic Pain: The Paradox of Dynorphin

Antinociceptive and nociceptive actions of opioids

Inhibition of pain responses by activation of CB(2) cannabinoid receptors

PERIPHERAL NERVE INJURY CAUSES MULTISEGMENTAL ALLODYNIA AND A MULTISEGMENTAL INCREASE IN SPINAL DYNORPHIN CONTENT

Suchergebnisse filtern